Premier Alternatives

BiomEdit

Other Agriculture · Greenfield, IN · Founded 2022 · Privately Held (backing)

Developer of a microbiome innovation platform designed to discover and develop animal health products. BiomEdit is based in Greenfield, IN and was founded in 2022. Its last reported valuation was $577 million in Feb 2023. It has raised $55.1 million across 2 recorded rounds; the latest was a $16 million early-stage round in Apr 2025.

Last reported valuation
$577.0M
Oct 2026
Priced at
—
Total raised
$55.1M
Last round
Early Stage VC
Apr 2025

BiomEdit key facts

as of Oct 2026
  • Developer of a microbiome innovation platform designed to discover and develop animal health products.
  • BiomEdit is valued at approximately $577.0M as of Oct 2026 (last reported valuation).
  • It has raised $55.1M across 2 recorded rounds; the latest was Early Stage VC ($16.0M) in Apr 2025.
  • Notable investors include Viking Global Investors, Gates Foundation, Elevate Ventures, Ginkgo Bioworks, AgriZeroNZ — 10 tracked in total.
  • BiomEdit has filed 1 Form D with the SEC, most recently Jun 2025 ($16.0M sold to 17 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$577.0M

BiomEdit's last reported valuation, Feb 2023. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of BiomEdit with a free account
  • ·Watch BiomEdit: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

BiomEdit funding rounds

2 rounds
Apr 2025Early Stage VC$16.0MSEC filing▮
Feb 2023Early Stage VC (Series A)$36.5M▮
Full funding history →

BiomEdit valuation

BiomEdit's last reported valuation was $577 million in Feb 2023. No priced round, secondary trade or fund mark has surfaced since.

How much has BiomEdit raised?

BiomEdit has raised $55.1 million across 2 recorded rounds since 2023. The largest was a $36.5 million Series A in Feb 2023; the most recent was a $16 million early-stage round in Apr 2025.

BiomEdit has filed 1 Form D with the SEC, most recently in Jun 2025 ($16 million sold to 17 investors).

BiomEdit investors

10 investors are on record for BiomEdit, including Viking Global Investors, Gates Foundation, Elevate Ventures and Ginkgo Bioworks. The early-stage round in Apr 2025 drew 17 investors.

About BiomEdit

Developer of a microbiome innovation platform designed to discover and develop animal health products. The company's platform utilizes microbiome-derived bioactive compounds and engineered microbial medicines to address unmet needs in animal health, enabling clients to enhance animal protein production and improve livestock disease monitoring.

Industry
Other Agriculture
Sector
Materials and Resources
HQ
Greenfield, IN, United States
Founded
2022
Employees
35
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.